|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/4412 | (2006.01) |
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2324831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10250379.4 |
| Date of filing the European patent application | 2010-03-03 | |
| (97) | Date of publication of the European application | 2011-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2011-09-28 |
| (46) | Date of publication of the claims translation | 2011-12-27 |
| (30) | Number | Date | Country code |
| 266815 P | 2009-12-04 | US | |
| 684879 | 2010-01-08 | US |
| (72) |
Bradford, Williamson Ziegler, US
Szwarcberg, Javier, US
|
| (73) |
Intermune, Inc.,
3280 Bayshore Boulevard, Brisbane, CA 94005-1021,
US
|
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Pirfenidono terapija vengiant fluvoksamino |
| Pirfenidone therapy avoiding fluvoxamine |
| Payment date | Validity (years) | Amount | |
| 2018-02-23 | 9 | 208.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2018-12-18 |